Eisen

Protocol Feasibility

Change in Total PANSS Score

Reference intervals for liver cT1

Complete remission of Type 2 Diabetes Mellitus at 12 Months Post-Surgery

Fractional iron absorption (%)

Change in GPX4 Gene Expression

Nausea-Vomiting-Retching Symptoms

Fractional iron absorption

Change in lipidomic markers among infants receiving Goat Milk-Derived Formula Alternative (GMDFA) compared to undiluted goat milk and breastfeeding groups.

Demonstrate the feasibility of a trimodal prehabilitation program with motivational strategies during chemotherapy in a multidisciplinary hospital setting.

57Fe tracer concentration in the circulation

Concentration of Blood Glucose (mg/dL)

Haemoglobin status change from baseline

The difference in the bioimpedance vectors between two groups of patients (active workers versus sedentary workers), according to BIVA

Fractional iron absorption

Change in ferritin levels from baseline to 12 months

Safety of the guidelines

Perioperative RBC transfusion requirement

serum iron level

Dietary intake assessment

Cardiac right ventricular mass

Adherence to the Dietary Intervention

Physiological biomarkers_Cardiopulmonary Exercise Testing (CPET)-(Peak VO2)

Change in the hemoglobin from baseline

Evaluation of Gastrointestinal Health

Change in serum ferritin

CBC with leukocyte formula and calculation of the NLR and PLR ratio

Feasibility of Adherence to the Intervention

Adverse events

Iron absorption

Electrogustometry

Percentage of Participants Achieving Transfusion Reduction Response (TRR)

Inflammatory Bowel Disease Questionnaire (IBDQ)

Change in anxiety and depressive symptoms

Diet-related greenhouse gas emissions reported as kilograms of carbon dioxide equivalents per day

Change in Haemoglobin (Hb) Concentration From Baseline to Week 12

Iron status: Serum Ferritin (ug/L) (SF)

Number of Participants Reporting Local Reactogenicity Signs and Symptoms Within 7 Days of Each H10ssF-6473 Product Administration

Effects of Serum Bovine Immunoglobulin (SBI) on nutrition of pediatric patients with inflammatory Bowel Disease

Changes in the percentage of dietary diversity (based on different food groups) from baseline.

a significant decrease of Plasma Phe levels in Group A

Small-for-Gestational-age (SGA)

Diagnostic accuracy of imaging biomarkers for severity of liver fibrosis on histology as reference standard

# of participants with all AEs as assessed by CTCAE V4.0 included injection site reaction, will be measured from baseline to post dose follow up

Relative abundance of Enterobacteriaceae

Number of Participants Reporting Local Reactogenicity Signs and Symptoms Within 7 Days of Each H1ssF_3928 Product Administration

prevalence of vascular cognitive impairment in patients given Ferrous succinate versus placebo

Biomarkers of vitamin A, iron, and zinc status

Hemoglobin centration

malondialdehyde

Efficacy of Deferiprone

Change on concentration of biochemical parameters for hunger sensation and hormonal status

No. of participants who become responders or partial responders

The Effect of Rhlactoferrin on Serum Levels of Interleukin-6 (IL-6)

Number of Participants Preferring Deferasirox FCT or DT at Week 48 Based on Preference Questionnaire (Item 2)

changes in blood intact FGF23 after infusion of 1000 mg ferric carboxymaltose

Proportion of Patients That Achieve Erythroid Hematologic Improvement.

Changes in means of differences in height

Calibration curve of liver R2* vs LIC measured by Ferriscan at each of the sites

Percentage of Group C Participants Who Achieved Complete Resolution of Vaso-occlusive Events (VOE-CR)

normal value serum ferritin

distribution of values of Hepcidin / ferritin plasma ratio

Change in the Taste Visual Analog Scale (VAS) and taste and smell questionnaire responses

Percentage of Participants Achieving an American College of Rheumatology (ACR) 20 Response at Week 12

To determine if the use of intravenous ferric carboxymaltose can reduce the need for allogeneic blood transfusion compare to oral ferrous sulphate in patients with colorectal adenocarcinoma related anaemia

Improvement in glucose area under the curve.

lymphocyte subgroups

intra-individual difference in TAFO between study start and study end

Change in Haemoglobin (Hb) Concentration From Baseline to Week 12 (Full Analysis Set, FAS)

Changes in GI microbiome

Segment-level Sensitivity and Specificity of VE-MRI at 3 Ferumoxytol Dosing Levels and Differences in Sensitivity and Specificity by Dose Group

Percentage of Participants Maintaining Their Mean Hemoglobin Concentration Within Plus or Minus 1 Gram/Deciliter of Their Reference Hemoglobin and Between the Target Range During Efficacy Evaluation Period

Effect of deferasirox on renal hemodynamics in patients with β-thalassemia and transfusional iron overload.

To evaluate the antioxidative effect of Exjade therapy in MDS patients

Changes from baseline in USPIO-enhanced MRI signal in carotid plaques at 6 weeks and 12-weeks in low and high dose atorvastatin groups (within groups' comparison).

Long Term Safety and Tolerability Profile of ICL670 Based on the Number of Participants Who Experienced Any Adverse Event